These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12682647)

  • 1. Reduced expression of H19 in bone marrow cells from chronic myeloproliferative disorders.
    Bock O; Schlué J; Kreipe H
    Leukemia; 2003 Apr; 17(4):815-6. PubMed ID: 12682647
    [No Abstract]   [Full Text] [Related]  

  • 2. Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern.
    Tessema M; Länger F; Bock O; Seltsam A; Metzig K; Hasemeier B; Kreipe H; Lehmann U
    Int J Oncol; 2005 Feb; 26(2):499-507. PubMed ID: 15645136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myeloproliferative disorders--introduction.
    Skoda R; Prchal JT
    Semin Hematol; 2005 Oct; 42(4):181-3. PubMed ID: 16210031
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders.
    Bock O; Schlué J; Mengel M; Büsche G; Serinsöz E; Kreipe H
    J Pathol; 2004 May; 203(1):609-15. PubMed ID: 15095485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcr-abl mRNA expression in patients with chronic myeloproliferative disorders--absence of bcr-abl fused clone except chronic myelocytic leukemia.
    Nakata Y
    Hiroshima J Med Sci; 1993 Jun; 42(2):67-71. PubMed ID: 8253600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
    J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
    Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
    Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
    Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia.
    Ruan GR; Qin YZ; Chen SS; Li JL; Ma X; Chang Y; Wang YZ; Fu JY; Liu YR
    Leuk Res; 2006 Sep; 30(9):1159-65. PubMed ID: 16507320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of chronic myeloproliferative syndromes using the technics of in vitro hematopoiesis (the origin and function of marrow stromal cells in CML)].
    Takahashi M; Fujiwara M
    Rinsho Ketsueki; 1988 Jul; 29(7):994-1000. PubMed ID: 3184486
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of Ha-ras in human chronic granulocytic and chronic myelomonocytic leukaemia.
    Gow J; Hughes D; Farr C; Hamblin T; Oscier D; Brown R; Padua RA
    Leuk Res; 1988; 12(10):805-10. PubMed ID: 3059070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myelogenous leukemia molecular signature.
    Nowicki MO; Pawlowski P; Fischer T; Hess G; Pawlowski T; Skorski T
    Oncogene; 2003 Jun; 22(25):3952-63. PubMed ID: 12813469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma].
    Wu J; Qin Y; Li B; He WZ; Sun ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):49-52. PubMed ID: 17294726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of insulin-like growth factor-2 (IGF-2) in Philadelphia chromosome negative chronic myeloproliferative disorders.
    Bock O; Tessema M; Serinsöz E; von Wasielewski R; Büsche G; Kreipe H
    Leuk Res; 2004 Nov; 28(11):1145-51. PubMed ID: 15380337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
    Barsyte-Lovejoy D; Lau SK; Boutros PC; Khosravi F; Jurisica I; Andrulis IL; Tsao MS; Penn LZ
    Cancer Res; 2006 May; 66(10):5330-7. PubMed ID: 16707459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutation.
    Hussein K; Bock O; Theophile K; Seegers A; Arps H; Basten O; Grips KH; Franz-Werner J; Büsche G; Kreipe H
    Leukemia; 2008 May; 22(5):1059-62. PubMed ID: 17972958
    [No Abstract]   [Full Text] [Related]  

  • 18. IGF2 but not H19 shows loss of imprinting in human glioma.
    Uyeno S; Aoki Y; Nata M; Sagisaka K; Kayama T; Yoshimoto T; Ono T
    Cancer Res; 1996 Dec; 56(23):5356-9. PubMed ID: 8968084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of bcr/abl gene expression on bone marrow cell colonies in chronic myelogenous leukemia by reverse transcriptase-polymerase chain reaction].
    Luo Z; Chen H; Luo S; Tang L; Wang J
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(5):418-20. PubMed ID: 12080671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 3' portion of the mouse H19 Imprinting-Control Region is required for proper tissue-specific expression of the Igf2 gene.
    Hagège H; Nasser R; Weber M; Milligan L; Aptel N; Jacquet C; Drewell RA; Dandolo L; Surani MA; Cathala G; Forné T
    Cytogenet Genome Res; 2006; 113(1-4):230-7. PubMed ID: 16575185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.